CTRI/2016/11/007511
Recruiting
Phase 4
Assessment of Efficacy, Tolerability and Safety of Steroneo Skin Cream (Physalis Angulata Supercritical Extract) application for treatment of eczematous lesions: A Prospective, Open-label, Non-Comparative Study
Rehmat Clinic0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Rehmat Clinic
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically diagnosed with eczematous lesions of any of the following types and requiring mild to moderate topical steroid therapy:
- •Atopic dermatitis
- •Contact dermatitis
- •Xerotic eczema
- •Nodular eczema
- •Seborrheic dermatitis
- •Neurocutaneous dermatitis (lichen simplex chronicus)
- •Drug eruptions, photo\-dermatitis
- •Pruritus requiring topical corticosteroids
- •Patients/parents who sign the written informed consent form
Exclusion Criteria
- •1\.Patients having any of the following conditions:
- •Lichen planus
- •Severe dermatitis requiring systemic corticosteroids
- •Infantile dermatitis
- •2\.Patients requiring systemic corticosteroids on any form
- •3\.Pregnant and lactating women
- •4\.Patients with known hypersensitivity to any of the ingredients/excipients of the study cream
- •5\.Any other condition, which in the opinion of the clinician/investigator, could interfere significantly with the treatment and assessment process
- •6\.Use of any investigational therapy within 30 days prior to randomization
- •7\.Patients not willing to provide written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Study of Efficacy, Safety and Tolerability of Na-Picosulphate in patients requiring anorectal surgeryHealth Condition 1: null- Patients requiring bowel preparation for gastrointestinal or anorectal surgeryCTRI/2016/09/007292VYAS SURGERY100
Completed
Phase 4
A Clinical trial to study the effects and tolerability of Dacne gel containing Clindamycin Phosphate 1% and zinc acetate in patients suffering from acne.CTRI/2011/091/000041Glenmark Pharmaceuticals Ltd125
Completed
Phase 4
Assessment of Efficacy, Safety and Tolerability of Fixed Dose Combination Wunder Eye Cream (3% Biophytex LS 8740 an 5% Proteasyl TP LS 8657) in the treatment of under Eye Dark Circles.CTRI/2011/04/001672Glenmark Pharmaceuticals Limited20
Completed
Phase 4
A clinical trial to study the effect of Hair4U 10% containing (minoxidil 10% plus Aminexil 1.5%)in treatment of male pattern of baldnessHealth Condition 1: null- Androgenetic AlopeciaCTRI/2011/06/001813Glenmark Pharmaceuticals Ltd75
Completed
N/A
Observational Study on cough syrupHealth Condition 1: null- productive cough (cough with expectoration) associated with any of the nasal symptoms (nasal discharge,nasal stuffiness, nasal itching, and Sneezing) since at least previous 8 hoursCTRI/2015/09/006198Dr Reddys laboratories Ltd250